Effect of Fenofibrate and Ezetimibe Combination Treatment on Lipid.
Phase of Trial: Phase III
Latest Information Update: 12 May 2016
At a glance
- Drugs Ezetimibe (Primary) ; Fenofibrate (Primary)
- Indications Hyperlipoproteinaemia type IIb
- Focus Therapeutic Use
- Acronyms EFECTL
- 05 Jan 2012 Planned end date changed from 1 Aug 2010 to 1 Dec 2014 as reported by University Hospital Medical Information Network - Japan.
- 21 Dec 2010 Actual initiation date changed from 2 Jun 2008 to Jul 2008 as reported by University Hospital Medical Information Network - Japan.
- 07 Jul 2008 New trial record.